Cost effectiveness of risk reduction: The managed care perspective

American Journal of Medicine

Volumn 101, Issue 4 A, 1996, Pages 71S-75S

  Shalowitz, Mervin ^a   Heaton, Alan H ^b  

^a UNITED HEALTHCARE   (United States)

^b Pharmacy Gold   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; PROBUCOL;

CONFERENCE PAPER; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; PRIORITY JOURNAL; RISK ASSESSMENT; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS;

COST-BENEFIT ANALYSIS; HUMANS; HYPERCHOLESTEROLEMIA; MANAGED CARE PROGRAMS; MYOCARDIAL INFARCTION; RISK ASSESSMENT;

EID: 0029661994     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00323-3     Document Type: Conference Paper

References (11)

1. Heart and Stroke Facts: 1995 Statistical Supplement, American Heart Association. 1994.
2. Pearson TA, McBride PE, Miller NH, Smith SC Jr. Organization of preventive cardiology service. JACC. 1996;27:1039-1047.
3. Heaton AH, Bryant J, Berman BN, Trotter JP. Pharmacoeconomic comparison of loop diuretics in the treatment of congestive heart failure. Medical Interfact. 1996;9:101-107.
4. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. J Chron Dis. 1978;31:201-306.
5. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256:2823-2828.
6. Goldman L, Gordon DJ, Rifkind BM, et al. Cost and health implications of cholesterol lowering. Circulation. 1992;85:1960-1968.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 1993;269:3015-3023.
8. Gotto AM, Pownall HJ. Management of lipid and lipoprotein disorders. In: Manual of Lipid Disorders. Baltimore: Williams & Wilkins, 1992:125-159.
9. Beta Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA. 1983;250:2814-2819.
10. MIAMI Trial Research Group. Metoprolol in acute myocardial infarction, a randomized placebo-controlled international trial. Eur Heart J. 1985;6:199-221.
11. Pfeffer MA, Braunwald E, Muyé LA, et al, on behalf of the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669-677.